Pulsenmore

Pulsenmore Enterprise Value

The Enterprise Value (EV) of Pulsenmore (PLSM.TA) as of Oct 21, 2026 is 40.77 M ILS. In the previous year, Enterprise Value (EV) was 7.64 M ILS — a change of 433.47% (higher).

Enterprise Value

40.77 MILS

YoY

433.47%

Last updated:

Enterprise Value (EV) of Pulsenmore is 2025 40.77 M ILS. Enterprise Value (EV) of Pulsenmore was 2024 7.64 M ILS. It decreases by 433.47% higher compared to the previous year.

The Pulsenmore Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2019
105.58 M ILS
Jan 1, 2020
103.29 M ILS
Jan 1, 2021
-44.01 M ILS
Jan 1, 2022
-64.29 M ILS
Jan 1, 2023
-26.62 M ILS
Jan 1, 2024
7.64 M ILS
Jan 1, 2025
40.77 M ILS
The Pulsenmore Enterprise Value history
YEAREnterprise ValueYoY
40.77 MILS+433.47%
7.64 MILS-128.70%
-26.62 MILS-58.59%
-64.29 MILS+46.09%
-44.01 MILS-142.61%
103.29 MILS-2.17%
105.58 MILS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pulsenmore Stock analysis

What does Pulsenmore do? Pulsenmore Ltd. generates revenue through the sale of its two miniaturized ultrasound systems, PulseNmore ES and PulseNmore FC, designed for home use in remote clinical diagnosis. The PulseNmore ES targets pregnant women requiring regular ultrasound monitoring, while PulseNmore FC caters to women undergoing in vitro fertilization needing follicle size assessments. Both systems integrate with smartphones, enabling patients to conduct tests at home and share results online with healthcare providers. The company also monetizes through software delivery for its devices, enhancing user experience and data management. The primary buyers of PulseNmore ES are pregnant women seeking convenient, clinic-free monitoring, and healthcare providers managing prenatal care remotely. PulseNmore FC is purchased by women undergoing in vitro fertilization, often through fertility clinics or medical centers that recommend the device. These segments value the convenience of home-based diagnostics and seamless telehealth integration without requiring in-person visits. Pulsenmore Ltd. focuses on global markets for its portable ultrasound solutions, serving patients in remote or underserved areas who benefit from telehealth-enabled diagnostics. The company’s products are positioned as cost-effective alternatives to traditional clinic visits, appealing to both end-users and healthcare institutions aiming to reduce operational costs while maintaining patient care quality. Pulsenmore is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pulsenmore stock

Enterprise Value (EV) of Pulsenmore is 40.77 M ILS in 2025.

Enterprise Value (EV) of Pulsenmore changed from 7.64 M ILS to 40.77 M ILS, representing a 433.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Pulsenmore since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s ILS, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' ILS varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Pulsenmore with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Pulsenmore

All Key Metrics — Pulsenmore